Compare SACH & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SACH | RPID |
|---|---|---|
| Founded | 2010 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 34.7M |
| IPO Year | 2016 | 2021 |
| Metric | SACH | RPID |
|---|---|---|
| Price | $0.69 | $0.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.75 |
| AVG Volume (30 Days) | 116.4K | ★ 160.4K |
| Earning Date | 11-24-2026 | 11-24-2026 |
| Dividend Yield | ★ 5.71% | N/A |
| EPS Growth | ★ 104.30 | 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $57,500,000.00 | $33,587,000.00 |
| Revenue This Year | $94.91 | $16.95 |
| Revenue Next Year | N/A | $17.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $0.69 | $0.58 |
| 52 Week High | $1.45 | $4.94 |
| Indicator | SACH | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 17.03 | 32.95 |
| Support Level | N/A | $0.58 |
| Resistance Level | $0.87 | $2.18 |
| Average True Range (ATR) | 0.03 | 0.07 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 4.31 | 31.73 |
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns the majority of its revenue through Interest income from loans.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.